On a rare, sunny winter Sunday, it seemed a shame to head indoors for Glaucoma New Zealand’s (GNZ’s) sixth symposium but, as always, it was a rewarding day which delivered excellent learning and
Barbie, Barbiemania and Barbiecore are buzzwords dominating the media over recent weeks. Ever since the premiere of Barbie, the world has been abuzz over the iconic doll-inspired movie.
A group of researchers associated with the Blind and Vision Education Network of New Zealand (BLENNZ), including myself, Dr Shuan Dai and Hadyn Treanor, undertook a study to assess the visual benefits of tinted and clear contact lenses (CLs) in akonga (students) with albinism. The aim was to assess
Running a successful optometry practice in New Zealand requires a combination of top-notch eyecare services and strategic approaches to maximise revenue. As the country’s healthcare landscape evolves,
In recent years there has been a healthy obsession with what we eat and its influence on our health and wellbeing. According to various studies, gut health has now been linked to the onset of
Held in Port Douglas, Queensland, this year’s Australasian Society of Cataract and Refractive Surgery (AUSCRS) conference was themed ‘A Whole New World’. It was appropriate, being the first AUSCRS
I was contacted by the family of Mr JM, a retired teacher. They were very worried that having always read every newspaper and copy of The New Zealand Listener from cover to cover, as well as having a library of books he was looking forward to getting into, he was now complaining he couldn’t read. Th
When it comes to salaries it is impossible to keep everyone happy. The recent controversy regarding optometrists’ salaries in New Zealand, triggered by a research report into salaries and the
Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration Hannah Khan Clinical Ophthalmology, 2023 Review: This review evaluated the current status of
One of the most exciting facets of being medical retina specialists is the continued evolution of age-related macular degeneration (AMD) therapies. We have come a long way from the days of
The optimal management of dry eye disease (DED) often seems an enigma. A recently published collaborative review, by Ocular Surface Laboratory (OSL) and Buchanan Ocular Therapeutics Unit (BOTU) researchers at the University of Auckland, outlined current anti-inflammatory options used in clinical man
Ocular health disparities between Māori and non-Māori are well-recognised1, with current epistemologies of Western medicine failing to acknowledge the holism of Māori health. Kaupapa Māori methodologies are important and help ensure Māori receive healthcare that reflects their principles and values